Download Full Volume - United States Renal Data System

More documents

Recommendations

Info

AINCIDENCE OF REPORTED ESRD Reference section A Table A.8 A.8 (continued) Incident counts of reported ESRD patients, by diabetic status & state/territory: all patients 302 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 Alabama 1,197 1,297 1,374 1,501 1,659 1,596 1,700 1,754 1,791 1,816 1,859 Alaska 45 136 219 69 81 66 72 87 91 80 98 Arizona 1,144 1,125 1,226 1,302 1,391 1,535 1,634 1,697 1,760 1,795 1,886 Arkansas 593 695 731 724 825 763 830 849 875 938 917 California 6,985 7,938 8,037 8,540 9,109 9,854 10,418 10,773 11,125 11,897 12,089 Colorado 558 576 556 672 689 781 762 783 783 848 828 Connecticut 748 863 847 901 916 942 991 1,018 958 994 962 Delaware 192 219 236 229 230 246 279 291 273 310 349 District of Columbia 374 357 394 392 404 407 417 455 432 445 451 Florida 3,934 4,256 4,343 4,881 5,101 5,177 5,549 5,748 5,970 6,250 6,344 Georgia 1,981 2,178 2,293 2,504 2,511 2,682 2,977 3,151 3,209 3,302 3,359 Hawaii 328 407 391 386 424 450 481 508 467 507 489 Idaho 141 174 191 213 226 218 259 253 282 259 267 Illinois 3,101 3,386 3,551 3,903 3,850 4,108 4,331 4,372 4,502 4,890 4,698 Indiana 1,308 1,333 1,402 1,542 1,615 1,829 1,802 1,898 1,920 2,026 2,001 Iowa 546 576 542 612 616 662 788 707 739 787 750 Kansas 438 501 494 575 657 660 676 688 658 720 724 Kentucky 831 881 903 971 1,044 1,143 1,231 1,229 1,274 1,270 1,330 Louisiana 1,400 1,525 1,602 1,620 1,847 2,007 2,133 2,015 2,181 2,323 2,385 Maine 177 194 226 215 265 268 258 297 296 312 326 Maryland 1,422 1,544 1,720 1,828 1,903 2,090 2,117 2,206 2,252 2,340 2,380 Massachusetts 1,345 1,396 1,372 1,509 1,572 1,629 1,599 1,696 1,621 1,698 1,777 Michigan 2,395 2,452 2,543 2,923 2,917 3,131 3,208 3,330 3,489 3,655 3,616 Minnesota 830 882 847 940 1,000 1,055 1,053 1,092 1,212 1,232 1,183 Mississippi 854 941 915 1,025 1,091 1,135 1,196 1,144 1,230 1,336 1,323 Missouri 1,296 1,383 1,439 1,522 1,634 1,797 1,820 1,877 1,918 1,839 1,981 Montana 147 141 162 157 145 154 194 165 208 172 190 Nebraska 296 315 330 357 409 428 466 490 529 483 490 Nevada 303 374 356 377 413 455 565 548 616 621 728 New Hampshire 156 183 182 167 206 222 253 271 246 273 282 New Jersey 2,333 2,502 2,627 2,642 2,874 3,046 3,256 3,137 3,277 3,334 3,390 New Mexico 377 373 428 476 488 474 555 571 561 547 600 New York 4,936 5,001 5,113 5,507 5,844 6,081 6,272 6,535 6,623 6,798 6,913 North Carolina 2,009 2,195 2,135 2,420 2,640 2,826 2,814 3,039 3,091 3,138 3,207 North Dakota 127 148 118 140 136 137 136 161 187 182 164 Ohio 2,603 2,911 3,003 3,440 3,441 3,749 3,985 4,264 4,184 4,361 4,482 Oklahoma 729 755 781 827 948 1,037 1,035 1,073 1,124 1,137 1,259 Oregon 552 568 571 604 641 672 718 740 786 855 902 Pennsylvania 3,077 3,495 3,589 3,951 4,136 4,213 4,424 4,547 4,460 4,781 4,492 Rhode Island 238 266 232 275 270 285 310 328 315 324 338 South Carolina 1,130 1,324 1,235 1,385 1,459 1,596 1,656 1,600 1,678 1,641 1,826 South Dakota 138 145 181 197 200 208 215 244 217 253 253 Tennessee 1,263 1,453 1,504 1,569 1,709 1,784 1,973 1,897 1,850 2,000 2,055 Texas 4,546 4,816 4,974 5,532 5,805 6,249 6,632 6,889 7,100 7,411 7,771 Utah 261 254 270 263 270 347 345 335 403 373 365 Vermont 83 80 101 111 111 117 128 122 101 132 139 Virginia 1,684 1,796 1,902 2,071 2,343 2,341 2,440 2,272 2,472 2,685 2,675 Washington 837 938 952 999 1,050 1,109 1,230 1,323 1,301 1,419 1,462 West Virginia 420 461 492 532 616 659 649 701 725 703 709 Wisconsin 965 1,053 1,068 1,168 1,229 1,359 1,320 1,390 1,468 1,591 1,633 Wyoming 51 44 66 70 70 75 82 87 85 80 89 American Samoa * 14 * 12 * * 20 21 18 15 20 Guam 40 44 50 63 69 67 73 67 83 96 93 Puerto Rico 800 858 853 938 963 1,040 1,115 1,108 1,154 1,224 1,295 Saipan * * 14 14 18 22 14 18 * 17 19 Virgin Islands 22 23 32 30 43 41 37 31 39 46 43 Foreign 42 43 33 31 31 39 26 39 28 27 16 Unknown 150 172 36 36 40 49 41 35 33 37 295 All 64,492 69,968 71,791 77,860 82,203 87,121 91,560 93,966 96,280 100,625 102,567 The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule. *Values for cells with 10 or fewer patients are suppressed. "." Zero values in this cell.
Table A.8 A.8 (continued) Incident counts of reported ESRD patients, by diabetic status & state/territory: diabetic patients INCIDENCE OF REPORTED ESRD 2005 Annual <strong>Data</strong> ReportA 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 Alabama 26 42 62 89 104 120 143 183 190 288 298 350 Alaska * * * * * * 11 * * 21 11 14 Arizona 64 85 116 144 167 181 236 296 287 363 354 439 Arkansas * 25 31 53 62 74 84 120 105 134 130 186 California 211 463 597 723 814 1,040 1,216 1,259 1,433 1,880 2,080 2,388 Colorado 38 42 51 69 81 96 137 135 156 183 189 213 Connecticut 29 60 64 93 112 150 138 148 147 185 212 245 Delaware * 12 16 * 17 25 29 29 51 59 52 70 District of Columbia * 24 43 35 48 70 57 53 48 70 86 95 Florida 126 203 267 298 368 427 585 657 682 810 929 1,047 Georgia 53 127 154 150 191 222 268 340 359 440 503 558 Hawaii 23 36 32 34 28 58 75 106 99 107 145 144 Idaho * * 16 22 19 16 28 36 36 50 49 41 Illinois 141 191 254 294 335 446 464 517 523 620 767 925 Indiana 43 83 78 130 131 154 159 225 252 259 361 413 Iowa 27 52 54 69 68 85 105 67 104 130 134 147 Kansas 24 32 53 52 67 63 59 78 99 106 135 162 Kentucky 38 46 49 80 105 95 112 146 143 176 237 281 Louisiana 31 60 77 76 133 131 186 211 312 357 365 467 Maine * 11 15 17 21 24 25 40 35 33 42 47 Maryland 37 76 93 115 137 181 159 213 215 313 382 454 Massachusetts 62 85 100 105 116 122 154 160 189 264 302 359 Michigan 176 209 230 255 291 336 417 403 504 612 703 790 Minnesota 71 84 99 121 158 144 168 202 192 241 264 286 Mississippi 25 36 44 52 79 80 98 108 148 178 229 256 Missouri 19 74 121 103 137 181 177 216 240 281 327 382 Montana * 12 * 15 24 22 17 27 33 52 59 62 Nebraska 16 33 28 35 32 38 46 58 66 83 80 103 Nevada 19 17 22 17 23 26 44 60 54 70 81 91 New Hampshire * * 11 15 16 20 20 28 35 42 41 45 New Jersey 114 159 198 241 240 311 350 378 442 497 641 692 New Mexico 27 33 43 69 67 61 88 108 135 135 130 202 New York 202 315 392 485 595 627 795 851 996 1,038 1,252 1,367 North Carolina 68 78 127 150 179 242 240 323 332 419 509 610 North Dakota * * * 17 21 18 25 24 36 52 43 39 Ohio 143 203 262 283 333 396 435 509 591 670 817 874 Oklahoma 25 40 66 82 91 101 132 145 210 194 257 265 Oregon 20 27 55 57 50 69 88 101 118 132 142 165 Pennsylvania 174 191 258 304 432 448 518 569 647 740 917 1,026 Rhode Island * 14 14 15 20 24 21 36 47 45 57 56 South Carolina 41 51 78 89 127 167 156 198 224 267 308 372 South Dakota * 23 12 19 29 32 26 37 47 36 32 52 Tennessee 34 47 76 98 116 132 135 201 215 333 349 379 Texas 158 267 398 422 545 633 697 812 1,006 1,333 1,541 1,683 Utah 33 35 32 38 59 53 66 67 84 66 91 87 Vermont * * 14 * * 16 * 15 * 25 21 32 Virginia 59 73 124 169 184 172 223 248 310 342 374 477 Washington 43 41 62 71 100 140 120 133 191 227 239 289 West Virginia 19 22 32 54 56 53 82 77 92 94 112 131 Wisconsin 77 84 126 118 159 147 185 226 237 281 305 359 Wyoming * * 11 * * 21 * 16 15 23 12 14 303 American Samoa . * * . . * * * * * * * Guam * . * * * * * * * 11 13 20 Puerto Rico 39 54 83 101 140 137 166 197 212 288 282 352 Saipan . . . . * . . * * * * * Virgin Islands . * * * * * * * * * * * Foreign . . * . * * * * . * * * Unknown 23 21 45 48 55 66 94 68 108 98 129 96 All 2,690 4,043 5,308 6,218 7,513 8,708 10,092 11,477 13,072 15,770 18,138 20,720 The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule. *Values for cells with 10 or fewer patients are suppressed. "." Zero values in this cell.
Page 1 and 2: Reference A Section Incidence of re
Page 3 and 4: ON OUR WEBSITE & CD Incident counts
Page 5 and 6: INCIDENCE OF REPORTED ESRD 2005 Ann
Page 7 and 8: ON OUR WEBSITE & CD Incident rates
Page 15 and 16: ON OUR WEBSITE & CD Median age at s
Page 17 and 18: ON OUR WEBSITE & CD Incidence of re
Page 19: ON OUR WEBSITE & CD Incident counts
Page 23 and 24: Table A.8 A.8 (continued) Incident
Page 35 and 36: Reference B Section Prevalence of r
Page 37 and 38: ON OUR WEBSITE & CD Point prevalent
Page 39 and 40: Table B.1 B.1 (continued) Point pre
Page 45 and 46: PREVALENCE OF REPORTED ESRD 2005 An
Page 49 and 50: ON OUR WEBSITE & CD Median age at s
Page 51 and 52: ON OUR WEBSITE & CD Prevalence of r
Page 55 and 56: Table B.8 B.8 (continued) PREVALENC
Page 57 and 58: Table B.8 B.8 (continued) PREVALENC
Page 59 and 60: Table B.9 B.9 Point prevalent rates
Page 67 and 68: Table B.11 B.11 Point prevalent rat
Page 69 and 70: PREVALENCE OF REPORTED ESRD 2005 An
Page 71 and 72:
Reference C Section Patient charact
Page 73 and 74:
PATIENT CHARACTERISTICS 2005 Annual
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
ON OUR WEBSITE & CD Mean eGFR by MD
Page 85 and 86:
Table C.14 C.14 Percent distributio
Page 87 and 88:
Reference D Section Treatment modal
Page 89 and 90:
TREATMENT MODALITIES 2005 Annual Da
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
ON OUR WEBSITE & CD Incident ESRD p
Page 109 and 110:
ON OUR WEBSITE & CD Treatment statu
Page 111 and 112:
Page 113 and 114:
ON OUR WEBSITE & CD Living ESRD pat
Page 115 and 116:
Reference E Section Transplantation
Page 117 and 118:
TRANSPLANTATION: 2005 Annual Data P
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
ON OUR WEBSITE & CD Median time in
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
ON OUR WEBSITE & CD Renal transplan
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Reference F Section Transplantation
Page 141 and 142:
ON OUR WEBSITE & CD 90-day death-ce
Page 143 and 144:
ON OUR WEBSITE & CD One-year death-
Page 145 and 146:
ON OUR WEBSITE & CD Two-year death-
Page 147 and 148:
ON OUR WEBSITE & CD Three-year deat
Page 149 and 150:
ON OUR WEBSITE & CD Five-year death
Page 151 and 152:
ON OUR WEBSITE & CD Ten-year graft
Page 153 and 154:
TRANSPLANTATION: 2005 Annual OUTCOM
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Table F.13 F.13 90-day survival wit
Page 165 and 166:
Table Table F.14 F.14 One-year surv
Page 167 and 168:
Page 169 and 170:
Table F.16 F.16 Three-year survival
Page 171 and 172:
Table Table F.17 F.17 Five-year sur
Page 173 and 174:
Table F.18 F.18 Ten-year survival w
Page 175 and 176:
Page 177 and 178:
Table F.20 F.20 (continued) One-yea
Page 179 and 180:
Table F.21 F.21 (continued) Two-yea
Page 181 and 182:
Table Table F.22 F.22 (continued) (
Page 183 and 184:
Table F.23 F.23 (continued) Five-ye
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
Page 191 and 192:
Page 193 and 194:
Reference G Section Morbidity & hos
Page 195 and 196:
ON OUR WEBSITE & CD jkfj Total admi
Page 197 and 198:
ON OUR WEBSITE & CD Total admission
Page 199 and 200:
ON OUR WEBSITE & CD Total admission
Page 201 and 202:
ON OUR WEBSITE & CD Hospital days p
Page 203 and 204:
ON OUR WEBSITE & CD Hospital days p
Page 205 and 206:
Table G.11 G.11 Inpatient utilizati
Page 207 and 208:
Page 209 and 210:
Page 211 and 212:
MORBIDITY & 2005 HOSPITALIZATIONG A
Page 213 and 214:
MORBIDITY & 2005 HOSPITALIZATIONG A
Page 215 and 216:
Reference H Section Mortality & cau
Page 217 and 218:
MORTALITY & CAUSES OF DEATH 2005 An
Page 219 and 220:
Page 221 and 222:
Page 223 and 224:
Page 225 and 226:
Page 227 and 228:
Page 229 and 230:
Page 231 and 232:
Table H.6 H.6 (continued) Annual mo
Page 233 and 234:
Page 235 and 236:
Table H.8 H.8 (continued) Annual mo
Page 237 and 238:
Page 239 and 240:
Table H.10 H.10 (continued) Annual
Page 241 and 242:
Page 243 and 244:
Page 245 and 246:
Page 247 and 248:
Page 249 and 250:
Table H.16 H.16 Annual mortality ra
Page 251 and 252:
Table H.17 H.17 (continued) Total p
Page 253 and 254:
Table H.18 H.18 (continued) MORTALI
Page 255 and 256:
Page 257 and 258:
Page 259 and 260:
Page 261 and 262:
Page 263 and 264:
Table H.24 H.24 Annual mortality ra
Page 265 and 266:
Page 267 and 268:
Table H.26 H.26 (continued) MORTALI
Page 269 and 270:
Page 271 and 272:
Page 273 and 274:
ON OUR WEBSITE & CD Mortality rates
Page 275 and 276:
Page 277 and 278:
Page 279 and 280:
Page 281 and 282:
Page 283 and 284:
Page 285 and 286:
Page 287 and 288:
Page 289 and 290:
Page 291 and 292:
Page 293 and 294:
Reference I Section Patient surviva
Page 295 and 296:
I PATIENT SURVIVAL 2005 Annual Data
Page 297 and 298:
Page 299 and 300:
Page 301 and 302:
Page 303 and 304:
Page 305 and 306:
Page 307 and 308:
Page 309 and 310:
Page 311 and 312:
Table I.8 (continued) Table Inciden
Page 313 and 314:
Page 315 and 316:
Page 317 and 318:
Page 319 and 320:
Page 321 and 322:
Page 323 and 324:
Page 325 and 326:
Page 327 and 328:
Page 329 and 330:
Page 331 and 332:
Page 333 and 334:
Page 335 and 336:
Page 337 and 338:
Page 339 and 340:
Page 341 and 342:
Page 343 and 344:
Page 345 and 346:
Page 347 and 348:
Page 349 and 350:
Page 351 and 352:
Page 353 and 354:
Page 355 and 356:
Page 357 and 358:
Page 359 and 360:
Page 361 and 362:
Page 363 and 364:
Page 365 and 366:
Page 367 and 368:
Page 369 and 370:
Page 371 and 372:
Reference J Section Provider charac
Page 373 and 374:
Table J.1 J.1 Certified dialysis &
Page 375 and 376:
Table J.5 J.5 Dialysis & transplant
Page 377 and 378:
PROVIDER CHARACTERISTICS 2005 Annua
Page 379 and 380:
Table J.13 J.13 Dialysis patients:
Page 381 and 382:
PROVIDER CHARACTERISTICS JReference
Page 383 and 384:
Reference K Section Medicare costs
Page 385 and 386:
Table K.1 K.1 Total Medicare costs
Page 387 and 388:
MEDICARE COSTS FOR ESRD 2005 Annual
Page 389 and 390:
Page 391 and 392:
Page 393 and 394:
Page 395 and 396:
Page 397 and 398:
Page 399 and 400:
Page 401 and 402:
Reference L Section Vascular access
Page 403 and 404:
Table L.1 L.1 Catheter insertions i
Page 405 and 406:
Table L.3 L.3 Graft insertions in p
Page 407 and 408:
VASCULAR 2005 Annual Data ACCESSL R
Page 409 and 410:
Page 411 and 412:
Page 413 and 414:
Page 415 and 416:
Page 417 and 418:
Page 419 and 420:
Page 421 and 422:
Table L.12 L.12 Arteriovenous fistu
Page 423 and 424:
Reference M Section Census populati
Page 425 and 426:
CENSUS POPULATIONS 2005 Annual Data
Page 427 and 428:
Page 429 and 430:
Page 431 and 432:
Page 433 and 434:
Table M.2 M.2 Resident population e
show all

Download Full Volume - United States Renal Data System

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?